Dosage Forms

Articles

AstraZeneca’s antibody combination has been authorized for use in Great Britain to prevent COVID-19 in high-risk populations and people for whom vaccination may not be effective.

AstraZeneca’s Antibody Combination Authorized for Use in Great Britain for Prevention of COVID-19

Moderna has reached an agreement with the Ministry of Health, Labor, and Welfare of Japan (MHLW) to supply Japan with an additional 70 million doses of its COVID-19 Booster Vaccine. 

Moderna and the Japanese Government Reach an Agreement to Supply Japan with Additional 70 Million Doses of Moderna’s COVID-19 Booster Vaccine

physIQ and CellCarta are conducting a study to evaluate individual patient response to vaccination using wearable biosensors.

physIQ and CellCarta Collaborate on Personalized Approach to Vaccine Development

EMA has recommended that possible side effects of Spikevax and Janssen COVID-19 vaccines be added to product information.

EMA Recommends Updated Product Information for Moderna and Janssen COVID-19 Vaccines 

NIH has launched one of the first Phase 1 clinical trials to examine mRNA technology for HIV.

NIH Launches Clinical Trial of Three mRNA HIV Vaccines

Johnson & Johnson have announced a landmark agreement to enable the manufacturing and availability of its COVID-19 vaccine in Africa by an African company.

Johnson & Johnson COVID-19 Vaccine to be Manufactured in Africa

Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.

Moderna to Establish its First mRNA Manufacturing Facility in Africa

Evonik has increased its global supply of plant-derived cholesterol used for mRNA vaccines and gene therapies.

Evonik Increases Global Supply of Pharma-Grade Plant-Derived Cholesterol for mRNA Vaccines and Gene Therapies

A consortium of nine development partners will support Biovac's expansion of its existing vaccine manufacturing plant capacity, while Biovac itself aims to raise funds to boost increased vaccine manufacturing capacity across Africa.

Biovac and Development Partners to Support Vaccine Manufacturing Expansion in South Africa

In a goal to boost local pharmaceutical production, the World Health Organization has established a global manufacturing training hub in the Republic of Korea through which Bangladesh, Indonesia, Pakistan, Serbia, and Vietnam will receive mRNA technology.